Algernon Launches First U.S. Brain-Dedicated PET Clinic in Florida — Grey Matters Health Inc.

Event summary

Algernon Health Inc. will open its first brain-dedicated PET scanning clinic in the U.S. at HCA Florida University Medical Office Building, with a five-year lease and renewal option.
The clinic will use the FDA-cleared CareMiBrain™ system, reducing patient radiation exposure by 25% compared to traditional PET/CT scanners.
Algernon has secured a CAD $4 million deal for four CareMiBrain™ systems, with an option to acquire six more for additional clinics.
The clinic targets Alzheimer’s disease detection and other neurological conditions, leveraging Medicare, Medicaid, and private insurance coverage.

The big picture

Algernon’s clinic launch addresses a critical gap in the U.S. healthcare system: the insufficient supply of PET/CT scanners for neurological diagnostics. With FDA-approved treatments like Leqembi and Kisunla driving demand, Algernon positions itself to capitalize on a billion-dollar market opportunity by offering specialized, lower-radiation brain imaging solutions.

What we're watching

Market Expansion: Whether Algernon can successfully scale its clinic network across the U.S. and meet the growing demand for brain-specific PET scans.
Regulatory Compliance: How the FDA-cleared CareMiBrain™ system will perform in real-world settings and whether it maintains compliance with evolving regulations.
Competitive Dynamics: The pace at which competitors like Eisai, Biogen, and Eli Lilly may respond to Algernon’s specialized diagnostic offerings.